Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nektar Therapeutics

46.52
+2.194.94%
Volume:1.11M
Turnover:51.26M
Market Cap:884.74M
PE:-4.89
High:47.74
Open:44.25
Low:43.45
Close:44.33
52wk High:47.74
52wk Low:6.48
Shares:19.02M
Float Shares:16.64M
Volume Ratio:1.23
T/O Rate:6.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.5163
EPS(LYR):-8.6765
ROE:-440.80%
ROA:-31.57%
PB:-36.54
PE(LYR):-5.36

Loading ...

May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Major Issues Report

Form 8-K - Current report
Apr 04, 2025

Major Issues Report

Form 8-K - Current report
Mar 29, 2025

Correspondence

Form CORRESP - Correspondence
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2025

Major Issues Report

Form 8-K - Current report
Feb 24, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2025

Major Issues Report

Form 8-K - Current report
Dec 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities